Laird Norton Wetherby Wealth Management’s Celgene Corp CELG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-14,625
| Closed | -$1.45M | – | 735 |
|
|
2019
Q3 | $1.45M | Buy |
14,625
+186
| +1% | +$17.7K | 0.15% | 154 |
|
|
2019
Q2 | $1.33M | Buy |
14,439
+1,624
| +13% | +$154K | 0.15% | 154 |
|
|
2019
Q1 | $1.21M | Buy |
12,815
+1,932
| +18% | +$169K | 0.15% | 142 |
|
|
2018
Q4 | $697K | Sell |
10,883
-1,343
| -11% | -$99.1K | 0.1% | 237 |
|
|
2018
Q3 | $1.09M | Buy |
12,226
+369
| +3% | +$32.6K | 0.14% | 173 |
|
|
2018
Q2 | $942K | Buy |
11,857
+603
| +5% | +$50.1K | 0.13% | 183 |
|
|
2018
Q1 | $1M | Sell |
11,254
-2,267
| -17% | -$218K | 0.14% | 176 |
|
|
2017
Q4 | $1.41M | Sell |
13,521
-1,280
| -9% | -$144K | 0.2% | 110 |
|
|
2017
Q3 | $2.16M | Buy |
14,801
+904
| +7% | +$123K | 0.32% | 66 |
|
|
2017
Q2 | $1.8M | Sell |
13,897
-1,130
| -8% | -$138K | 0.31% | 66 |
|
|
2017
Q1 | $1.87M | Buy |
15,027
+270
| +2% | +$32.3K | 0.34% | 63 |
|
|
2016
Q4 | $1.71M | Buy |
14,757
+348
| +2% | +$38.8K | 0.33% | 59 |
|
|
2016
Q3 | $1.51M | Buy |
14,409
+2,199
| +18% | +$238K | 0.3% | 62 |
|
|
2016
Q2 | $1.2M | Buy |
12,210
+833
| +7% | +$86.2K | 0.27% | 81 |
|
|
2016
Q1 | $1.14M | Buy |
11,377
+373
| +3% | +$38.4K | 0.27% | 80 |
|
|
2015
Q4 | $1.32M | Sell |
11,004
-1,257
| -10% | -$145K | 0.32% | 66 |
|
|
2015
Q3 | $1.33M | Buy |
12,261
+650
| +6% | +$80.7K | 0.34% | 62 |
|
|
2015
Q2 | $1.34M | Buy |
11,611
+273
| +2% | +$31.2K | 0.32% | 65 |
|
|
2015
Q1 | $1.31M | Buy |
11,338
+228
| +2% | +$27.2K | 0.32% | 65 |
|
|
2014
Q4 | $1.24M | Sell |
11,110
-107
| -1% | -$11.3K | 0.31% | 64 |
|
|
2014
Q3 | $1.06M | Buy |
11,217
+241
| +2% | +$21.7K | 0.3% | 73 |
|
|
2014
Q2 | $942K | Sell |
10,976
-286
| -3% | -$21.7K | 0.27% | 86 |
|
|
2014
Q1 | $786K | Sell |
11,262
-436
| -4% | -$34.5K | 0.23% | 103 |
|
|
2013
Q4 | $988K | Buy |
11,698
+1,096
| +10% | +$86.7K | 0.28% | 82 |
|
|
2013
Q3 | $817K | Buy |
10,602
+720
| +7% | +$50.5K | 0.25% | 93 |
|
|
2013
Q2 | $578K | Buy |
+9,882
| New | +$595K | 0.2% | 116 |
|
Other funds holding CELG
FP
HCM
PCMC
WCG
Laird Norton Wetherby Wealth Management's CELG Position: Q4 2019 in Review
Laird Norton Wetherby Wealth Management sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 14,625 shares — an estimated $1.45M sold.
Laird Norton Wetherby Wealth Management first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $2.16M in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.
- Laird Norton Wetherby Wealth Management reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
- Laird Norton Wetherby Wealth Management sold 14,625 Celgene Corp shares in Q4 2019, an estimated $1.45M.
- Laird Norton Wetherby Wealth Management first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
- Laird Norton Wetherby Wealth Management's Celgene Corp position peaked at $2.16M in Q3 2017.
- 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.
Based on Laird Norton Wetherby Wealth Management's 13F filing for Q4 2019, filed 28 Jan 2020.